Clinical Trial Update: A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. [Phase 1]

View source ↗

Summary

This clinical trial update summarizes a Phase 1 safety and dose-finding study of JNJ-26481585 in patients with advanced solid malignancies and lymphoma; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Neoplasms

Drugs mentioned

• JNJ-26481585

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Lymphoma, Neoplasms | Phase 1 | Status: COMPLETED